Fourth Iteration of Adaptive COVID-19 Treatment Trial Underway
The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, announced that the fourth iteration of the Adaptive COVID-19…
National Institutes of Health
Can Vitamin D Supplements Prevent COVID-19 or Reduce Symptoms?
Funding from the National Institutes of Health will enable a Penn State researcher to study whether vitamin D supplementation could help people ward off or…
MIT Chemists Discover the Structure of a Key Coronavirus Protein
The protein, which acts as an ion channel, could be a target for new drugs against the SARS-CoV-2 virus. MIT chemists have determined the molecular…
NIH Trial Finds No Benefit From Hydroxychloroquine in Adults Hospitalized With COVID-19
A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has…
Plant Compound Apigenin Reduces Cognitive Deficits in Mouse Model of Down Syndrome
Mice treated with apigenin had better memory and developmental milestone scores. The plant compound apigenin improved the cognitive and memory deficits usually seen in a…
Scientists Restore Vision in Blind Mice Using Gene Therapy – Next, Human Testing
Scientists use gene therapy and a novel light-sensing protein to restore vision in mice. NIH-funded therapy will now be tested in humans. A newly developed…
Gene Discovered That Helps Us Know When It’s Time to Urinate
In a National Institutes of Health-funded study involving both mice and patients who are part of an NIH Clinical Center trial, researchers discovered that a…
New NIH Research Aims To Identify Promising COVID-19 Treatments for Larger Clinical Trials
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, launched a study on October 13, 2020, designed to…
NIH Testing Hyperimmune Intravenous Immunoglobulin Plus Remdesivir to Treat COVID-19
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir…
National Institutes of Health Launches Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19
The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in…
Discovery of Ancient Singing Dog Species May Teach Us About Human Vocalization
The finding marks a new effort in conserving an ancient dog breed, with potential to inform human vocalization processes. In a study published in PNAS,…
NIH-Moderna Investigational COVID-19 Vaccine Shows Promise
Vaccine shows promise in mouse studies and is currently being evaluated in Phase 3 clinical testing. The investigational vaccine known as mRNA-1273 protected mice from…
Multifocal Contact Lenses Slow Progression of Nearsightedness in Children
NIH-funded clinical trial provides independent evidence that multifocal contact lenses reduce worsening myopia. Children wearing multifocal contact lenses had slower progression of their myopia, according…
Monoclonal Antibodies to Prevent COVID-19: Phase 3 Clinical Trials Now Enrolling
Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs) can prevent infection by SARS-CoV-2 coronavirus are now enrolling healthy adults…
Scientists Monitor Brains Replaying Memories in Real Time
NIH study suggests our brains use distinct firing patterns to store and replay memories. In a study of epilepsy patients, researchers at the National Institutes…
NIH Harnesses Artificial Intelligence for COVID-19 Diagnosis, Treatment, and Monitoring
Collaborative network to enlist medical imaging and clinical data sciences to reveal unique features of COVID-19. The National Institutes of Health has launched the Medical…
NIH Launches ACTIV-3 Clinical Trial to Test Antibody Treatments in Hospitalized COVID-19 Patients
Study aims to determine safety and efficacy of experimental monoclonal antibodies. Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a…
Incredible New COVID-19 Testing Technologies
Range of new technologies will meet testing needs in diverse settings. The National Institutes of Health is investing $248.7 million in new technologies to address…